Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 10 of 12 Clinical Trials
ID/Name Source Type
221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
NCT02477800 clinicaltrials.gov Clinical Trial
221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease
NCT02484547 clinicaltrials.gov Clinical Trial
A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.
NCT03507790 clinicaltrials.gov Clinical Trial
Absolute Bioavailability of a Single, Fixed Subcutaneous Dose of Aducanumab in Healthy Participants
NCT02782975 clinicaltrials.gov Clinical Trial
Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease
NCT02907567 clinicaltrials.gov Clinical Trial
Effect of CT1812 Treatment on Brain Synaptic Density
NCT03493282 clinicaltrials.gov Clinical Trial
Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's Disease
NCT01677572 clinicaltrials.gov Clinical Trial
Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease
NCT03352557 clinicaltrials.gov Clinical Trial
Single and Multiple Ascending Dose Study of Aducanumab (BIIB037) in Japanese Participants With Alzheimer's Disease
NCT02434718 clinicaltrials.gov Clinical Trial
Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease
NCT01397539 clinicaltrials.gov Clinical Trial